Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Neuromodulator Signaling Bidirectionally Controls Vesicle Numbers in Human Synapses.

Patzke C, Brockmann MM, Dai J, Gan KJ, Grauel MK, Fenske P, Liu Y, Acuna C, Rosenmund C, Südhof TC.

Cell. 2019 Oct 3;179(2):498-513.e22. doi: 10.1016/j.cell.2019.09.011.

PMID:
31585084
2.

Equipotent doses of daunorubicin and idarubicin for AML: a meta-analysis of clinical trials versus in vitro estimation.

Adige S, Lapidus RG, Carter-Cooper BA, Duffy A, Patzke C, Law JY, Baer MR, Ambulos NP, Zou Y, Bentzen SM, Emadi A.

Cancer Chemother Pharmacol. 2019 Jun;83(6):1105-1112. doi: 10.1007/s00280-019-03825-2. Epub 2019 Apr 9.

PMID:
30968179
3.

Optimizing pegylated asparaginase use: An institutional guideline for dosing, monitoring, and management.

Bade NA, Lu C, Patzke CL, Baer MR, Duong VH, Law JY, Lee ST, Sausville EA, Zimrin AB, Duffy AP, Lawson J, Emadi A.

J Oncol Pharm Pract. 2019 Mar 27:1078155219838316. doi: 10.1177/1078155219838316. [Epub ahead of print]

PMID:
30917738
4.

A Retrospective Analysis of Prolonged Empiric Antibiotic Therapy for Pneumonia Among Adult Neurocritical Care Patients.

Patzke CL, Armahizer MJ, Badjatia N, Motta M.

Neurohospitalist. 2019 Jan;9(1):15-21. doi: 10.1177/1941874418792138. Epub 2018 Sep 9.

PMID:
30671159
5.

The fragile X mutation impairs homeostatic plasticity in human neurons by blocking synaptic retinoic acid signaling.

Zhang Z, Marro SG, Zhang Y, Arendt KL, Patzke C, Zhou B, Fair T, Yang N, Südhof TC, Wernig M, Chen L.

Sci Transl Med. 2018 Aug 1;10(452). pii: eaar4338. doi: 10.1126/scitranslmed.aar4338.

6.

Addressing Administration Challenges Associated With Blinatumomab Infusions: A Multidisciplinary Approach.

Szoch S, Boord C, Duffy A, Patzke C.

J Infus Nurs. 2018 Jul/Aug;41(4):241-246. doi: 10.1097/NAN.0000000000000283.

PMID:
29958260
7.

Comparison of prescribing patterns between United States and Dominican Republic prescribers on short-term medical mission trips.

Prescott GM, Patzke CL, Brody PM Jr, Prescott WA Jr.

Int Health. 2018 Jan 1;10(1):27-32. doi: 10.1093/inthealth/ihx045.

PMID:
29309591
8.

The conditional KO approach: Cre/Lox technology in human neurons.

Patzke C, Südhof TC.

Rare Dis. 2016 Feb 18;4(1):e1131884. doi: 10.1080/21675511.2015.1131884. eCollection 2016.

9.

Conditional deletion of L1CAM in human neurons impairs both axonal and dendritic arborization and action potential generation.

Patzke C, Acuna C, Giam LR, Wernig M, Südhof TC.

J Exp Med. 2016 Apr 4;213(4):499-515. doi: 10.1084/jem.20150951. Epub 2016 Mar 21.

10.

Autism-associated SHANK3 haploinsufficiency causes Ih channelopathy in human neurons.

Yi F, Danko T, Botelho SC, Patzke C, Pak C, Wernig M, Südhof TC.

Science. 2016 May 6;352(6286):aaf2669. doi: 10.1126/science.aaf2669. Epub 2016 Mar 10.

11.

Analysis of conditional heterozygous STXBP1 mutations in human neurons.

Patzke C, Han Y, Covy J, Yi F, Maxeiner S, Wernig M, Südhof TC.

J Clin Invest. 2015 Sep;125(9):3560-71. doi: 10.1172/JCI78612. Epub 2015 Aug 17.

12.

Rapid single-step induction of functional neurons from human pluripotent stem cells.

Zhang Y, Pak C, Han Y, Ahlenius H, Zhang Z, Chanda S, Marro S, Patzke C, Acuna C, Covy J, Xu W, Yang N, Danko T, Chen L, Wernig M, Südhof TC.

Neuron. 2013 Jun 5;78(5):785-98. doi: 10.1016/j.neuron.2013.05.029.

13.

The coxsackievirus-adenovirus receptor reveals complex homophilic and heterophilic interactions on neural cells.

Patzke C, Max KE, Behlke J, Schreiber J, Schmidt H, Dorner AA, Kröger S, Henning M, Otto A, Heinemann U, Rathjen FG.

J Neurosci. 2010 Feb 24;30(8):2897-910. doi: 10.1523/JNEUROSCI.5725-09.2010.

Supplemental Content

Loading ...
Support Center